12 HR guaifenesin 600 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Table... — RxCUI 1305603
RxNorm drug concept · Semantic clinical drug
RxCUI 1305603
Semantic clinical drug · SCD
● Current RxNorm concept 35 FDA products
60 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1305603
Official name12 HR guaifenesin 600 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asguaiFENesin 600 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet
FDA products mapped35
Package NDCs mapped60
Reported Medicaid activity (SDUD)2,482 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Guaifenesin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Guaifenesin is what's called an expectorant — it works to thin and loosen the mucus sitting in your chest and airways. That makes it easier to cough the mucus up and out, so instea...
- What exactly does guaifenesin do for my cough?
- Guaifenesin is meant for short-term use. If your cough isn't getting better after 7 days, keeps coming back, or shows up alongside a fever, rash, or a headache that won't go away,...
- How long can I take it before I should call my doctor?
🕸️ Concept Web — How 12 HR guaifenesin 600 MG / pseudoephedrine hydro... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
12 HR guaifenesin 600 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet
RxCUI 1305603 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Guaifenesin
5032IN -
Pseudoephedrine
8896IN -
Guaifenesin / pseudoephedrine
214599MIN -
Pseudoephedrine hydrochloride
91168PIN
-
Guaifenesin
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Guaifenesin / pseudoephedrine Extended Release Oral Tablet
373692SCDF -
Guaifenesin / pseudoephedrine hydrochloride Extended Release Oral Tablet
2646950SCDFP -
Guaifenesin / pseudoephedrine Oral Product
1159127SCDG -
Guaifenesin / pseudoephedrine Pill
1159128SCDG -
Guaifenesin / pseudoephedrine hydrochloride Oral Product
2659873SCDGP -
Guaifenesin / pseudoephedrine hydrochloride Pill
2659515SCDGP -
Extended Release Oral Tablet
316945DF -
Oral Product
1151131DFG - +1 more in this family
-
Guaifenesin / pseudoephedrine Extended Release Oral Tablet
-
Clinical & branded drugs 2
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Guaifenesin 600 MG
316020SCDC -
Pseudoephedrine hydrochloride 60 MG
996721SCDC
-
Guaifenesin 600 MG
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Guaifenesin 600 MG
SCDC · 316020 -
Pseudoephedrine hydrochloride 60 MG
SCDC · 996721 -
Guaifenesin / pseudoephedrine Extended Release Oral Tablet
SCDF · 373692 -
Guaifenesin / pseudoephedrine hydrochloride Extended Release Oral Tablet
SCDFP · 2646950 -
Guaifenesin / pseudoephedrine Oral Product
SCDG · 1159127 -
Guaifenesin / pseudoephedrine Pill
SCDG · 1159128 -
Guaifenesin / pseudoephedrine hydrochloride Oral Product
SCDGP · 2659873 -
Guaifenesin / pseudoephedrine hydrochloride Pill
SCDGP · 2659515
📦 FDA Products & Package NDCs
35 products · 60 package NDCs
60 package NDCs map to RxCUI 1305603 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 69842-0095-18 | 1 BLISTER PACK in 1 CARTON (69842-095-18) / 18 TABLET, EXTE... | Mucus D | CVS Health Corp | 2020-07-01 |
| 69842-0095-36 | 2 BLISTER PACK in 1 CARTON (69842-095-36) / 18 TABLET, EXTE... | Mucus D | CVS Health Corp | 2020-07-01 |
| 70000-0720-01 | 1 BLISTER PACK in 1 CARTON (70000-0720-1) / 18 TABLET, MULT... | Leader Mucus Relief D | Cardinal Health 110, LLC. dba Leader | 2025-03-10 |
| 70000-0720-02 | 2 BLISTER PACK in 1 CARTON (70000-0720-2) / 18 TABLET, MULT... | Leader Mucus Relief D | Cardinal Health 110, LLC. dba Leader | 2025-03-10 |
| 70677-1011-01 | 1 BLISTER PACK in 1 CARTON (70677-1011-1) / 18 TABLET, EXTE... | Guaifenesin and Pseudoephedrine HCl | Strategic Sourcing Services, LLC | 2023-05-05 |
| 70677-1263-01 | 1 BLISTER PACK in 1 CARTON (70677-1263-1) / 18 TABLET, EXTE... | Guaifenesin and Pseudoephedrine HCl | Strategic Sourcing Services LLC | 2024-12-13 |
| 70677-1272-01 | 2 BLISTER PACK in 1 CARTON (70677-1272-1) / 18 TABLET, MULT... | foster and thrive mucus relief d | Strategic Sourcing Services LLC | 2024-11-21 |
| 79481-0709-01 | 1 BLISTER PACK in 1 CARTON (79481-0709-1) / 18 TABLET, MULT... | Mucus D | Meijer, Inc. | 2025-01-07 |
| 79481-1002-01 | 1 BLISTER PACK in 1 CARTON (79481-1002-1) / 18 TABLET, EXTE... | Guaifenesin and Pseudoephedrine HCl | Meijer | 2021-07-15 |
| 79903-0125-36 | 2 BLISTER PACK in 1 CARTON (79903-125-36) / 18 TABLET, MULT... | equate mucus d | WALMART INC. | 2022-10-01 |
Observed labelers:
Dr. Reddys Laboratories Limited (9) ·
WALGREEN COMPANY (5) ·
Kroger Company (4) ·
Walgreens Company (4) ·
Strategic Sourcing Services LLC (3) ·
A-S Medication Solutions (2)
· +20 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.